A federal jury in Ohio has awarded $5 million in the first case to go to trial in the multidistrict litigation involving patients who claim injury from the body scan contrast agent gadolinium.

Tagged with: gadolinium GE Healthcare MDL multidistrict litigation nephrogenic systemic fibrosis Omniscan product liability

The first bellwether trial in the gadolinium nephrogenic systemic fibrosis suits is set for January 2011.

Tagged with: FDA Food and Drug Administration gadolinium magnetic resonance imaging MRI nephrogenic systemic fibrosis NSF

The Food and Drug Administration is adding its strongest label and warning doctors about a rare condition in patients with kidney disease caused by gadolinium, a contrast dye used in MRIs and other imaging scans.

Tagged with: Bayer FDA Food and Drug Administration gadolinium MRI nephrogenic systemic fibrosis